Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 23, 2021

View Archived Issues

Albireo Pharma presents preclinical data on HBV entry inhibitor A-2342

Researchers develop a rat model of oxycodone/cocaine withdrawal syndrome

B-cell GABA release blunts tumor immune response

New antibacterials identified at Roche

Iomx Therapeutics divulges new SIK2/SIK3 inhibitors

BeiGene describes BTK-targeting PROTACs

Jiangsu Hengrui Medicine and collaborators patent inositol derivatives

New kappa-opioid receptor agonists discovered at Medshine Discovery

Novel mouse model of focal limbic seizures with impaired behavior

PTSD model developed in Jeju minipig

Bristol Myers Squibb adds structurally diverse compounds to BET inhibitor candidates

Erythrocyte miR-210 as target for prevention of endothelial dysfunction in type 2 diabetes

KAND-145 + cisplatin reduces tumor size in disease model of chemotherapy-resistant ovarian cancer

Guard reports preclinical data on ROSgard in animal models of sepsis

Sanyou presents SYZJ-001 bispecific antibody drug against COVID-19

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...